TheEdgeResearch
Home / Stocks / DHBUF

Delivra Health Brands Inc. (DHBUF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.06 ▼ -19.97%
Market Cap
$1.9M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.89
52-Wk Range
0.0444-0.2612
CEO
Gord Davey
Country
CA
Currency
USD

Delivra Health Brands Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.06, down 19.97% on the session, giving a market capitalisation of $1.9M. On trailing twelve-month figures it carries a trailing P/E of -2.78, a net margin of -9.0%. Its beta of 0.89 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-2.78
Price / Sales
0.25
Price / Book
0.96
EV / EBITDA
-4.95
Gross margin
45.5%
Operating margin
-8.5%
Net margin
-9.0%
Return on equity
Debt / equity
0.79
Current ratio
3.29
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
22
IPO date
2017-05-02
Headquarters
Vancouver, BC, CA
About Delivra Health Brands Inc.

Delivra Health Brands Inc., leveraging its operational subsidiaries, provides a varied selection of wellness and lifestyle products. These offerings are distributed to consumers and patients within regulated markets globally. The company's diverse product range includes cannabis-based items, liquid and powdered formulations for sleep, and topical creams designed for pain relief. Delivra Health Brands' primary corporate office is located in Vancouver, Canada.

Comparable companies

Delivra Health Brands Inc. is most often compared with the following Healthcare names:

AYRWFAYURFCBIHCLCFFCRRTFCVSIHYEXIONKFLOBEFTWSI
More research on DHBUF
DHBUF technical analysis DHBUF TheEdge Score Compare against peers
Open full interactive analysis & DCF →